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Abstract
Introduction The dysfunction and decrease of endothelial
progenitor cells (EPCs) may play a very important role in the
initiation of organ dysfunction caused by trauma or severe
sepsis. We aim to measure the number and function of EPCs in
the progression of multiple organ dysfunction syndromes
(MODS) caused by severe sepsis, which may help to
understand the pathogenesis of MODS by the changing of
EPCs.
Methods A total of 40 pigs were randomly divided into two
groups, which were subjected to hemorrhagic shock,
resuscitation and endotoxemia (experimental group, n = 20) or
acted as a control (control group, n = 20). The number and
function of EPCs including adhesive, migratory and
angiogenesis capacities were analyzed at different times in both
groups.
Results All the animals in the experimental group developed
MODS (100%) and 17 of 20 animals (85%) died due to MODS;
the incidence of MODS and death of the animals in the control
group were 0% (P < 0.01). The number, migratory and adhesive
capacities of EPCs decreased sharply in the animals of the
experimental group corresponding to the increasing severities of
MODS, but the angiogenesis function increased gradually until
death. The decrease in function of EPCs preceded the decrease
in number of EPCs. The decrease in number and function of
EPCs occurred prior to the occurrence of MODS.
Conclusions For the first time, it was observed that the number
and function of EPCs decreased sharply in the progression of
MODS and that it was prior to the occurrence of MODS. The
decrease in number and function of EPCs may be one of the
main pathogenic factors of MODS.
Introduction
The endothelial cells (ECs) play a pivotal role in the progres-
sion of multiple organ dysfunction syndromes (MODS) caused
by trauma or severe sepsis; the ECs are not only the partici-
pant of inflammatory reaction, but also the first damaged target
cells. The dysfunction of ECs is a critical event in the initiation
of organ dysfunction [1].
Recent studies suggested that the injured ECs could be
regenerated by circulating bone marrow-derived progenitor
cells called endothelial progenitor cells (EPCs), which had
capabilities to mobilize from bone marrow with homing to foci
of injuries and to differentiate into mature ECs to ameliorate
the dysfunction of ischemic organs caused by trauma or
severe sepsis. This procession was possibly induced and
modulated by vasculogenesis and angiogenesis in areas with
reduced oxygen and circulation supply or by stimulating the re-
endothelialization of injured circulation vessels [2,3]. The
impairment of EPCs caused by severe inflammation may there-
fore contribute to the progression of multiple organ dysfunc-
tion.
Following the first description of isolation of putative EPCs for
angiogenesis by Asahara and colleagues in 1997 [4], increas-
CEPC: circulation endothelial progenitor cell; Dil-ac-LDL: 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine-labeled acetylated low-density lipo-
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ing evidence indicated that bone marrow-derived circulating
EPCs were involved in the process of neovascularization.
EPCs were considered to originate from hematopoietic stem
cells, which are positive for CD133 and the vascular endothe-
lial growth factor receptor-2 (KDR) in the early stage.
Several lines of evidence now suggest that the ischemia of
organs after trauma or severe sepsis would be the most impor-
tant pathogenesis of MODS [5,6]. We therefore hypothesized
that the number and function of circulating EPCs released
from bone marrow would decrease sharply after major trauma,
which would serve as early target cells in pathogenesis of
MODS. The regularity of the number and function of EPCs in
MODS, however, remained unclear. To verify our hypotheses,
we set up an animal model of MODS and serially sampled
blood and bone marrow from the model at the 24th hour
before operation and at the 12th, 24th, 72nd, 96th, 144th and
168th hour after severe trauma to observe the dynamic varia-
tion of bone marrow and circulating EPCs in the various
stages of MODS caused by two-hit injuries, including the
number and function of EPCs.
Materials and methods
Animals
All experiments were performed in accordance with the China
legislation on protection of animals and the 1996 National
Institutes of Health Guide for the Care and Use of Laboratory
Animals [7]. A total of 40 domestic male pigs with a body
weight of 20 to 25 kg (22.41 ± 1.33 kg) were used for the
present study. The animals were kept at 20 to 25°C all of the
time, with daylight and free access to tap water and standard
daily food. One day before the experiments, the animals were
kept fasting overnight with free access to water. Forty pigs
were divided randomly into two groups, which were subjected
to hemorrhagic shock + resuscitation + endotoxemia (experi-
mental group, n = 20) and the control group (n = 20).
Anesthesia and positioning
After an intramuscular injection of 15 mg/kg ketamin hydro-
chloride (Pfizer, Karlsruhe, Germany), 0.4 mg/kg diazepam
(Sunrise, Shanghai, China) and 0.02 mg/kg atropine (Braun,
Melsungen, Germany) for premedication, general anesthesia
was induced by intravenous injection of 1 mg/kg etomidate
(Braun). Anesthesia was maintained by continuous intrave-
nous injection administration of ketamin hydrochloride (5 to 10
mg/kg/hour; Pfizer) and diazepam (0.1 to 0.2 mg/kg/hour;
Sunrise). Oral intubation was performed (7.5 ET Tube; Bezer,
Shanghai, China) and the animals were mechanically venti-
lated (Evita, Dräger, Lübeck, Germany), volume cycled with a
tidal volume of 10 ml/kg. The respiratory frequency was
adjusted to maintain the peak inspiratory pressure below 30
mmHg, and an inspiratory oxygen concentration of 30% with
a positive end-expiratory pressure of 2 cmH2O and an inspira-
tory/expiratory ratio of 1:2 were used. Cardiac and respiratory
parameters were monitored throughout the procedures. The
animals were positioned in the lateral decubitus position, alter-
nating their right side and left side for bilateral access. Upon
completion of the experiment, the survival animals were eutha-
nized by overdosed intravenous injections of pentobarbital
sodium (Tianyi, Xian, China).
Operation
All of the experimental animals in the two groups underwent
the same operation under aseptic conditions. Individual ana-
tomical landmarks were marked on the animal's skin, including
the cartilage thyroidea, the articulatio sternoclavicularis, the
acromion, the inferior scapular angle, the pubic symphysis and
the anterior superior iliac spine. First of all, the arteria carotis
interna was dissected and intubated with a 12 G retention
catheter (Arrow, Leeds, UK) to monitor the arterial blood pres-
sure. The left femoral artery and femoral vein were then dis-
sected and intubated with an 8 F Swan-Ganz catheter (Arrow)
into the femoral vein to monitor the pulmonary arterial pres-
sure, the pulmonary arterial wedge pressure, the ventricular
stroke output and the central venous pressure. A retention
catheter was intubated into the right femoral artery for exsan-
guination and all catheters were fixed. The skin of the animals
was then sutured.
Hemorrhagic shock, resuscitation and endotoxemia
The animals of the experimental group underwent hemorrhagic
shock, resuscitation and endotoxemia after the operation. The
hemorrhagic shock model was not induced by a modified Wig-
ger's procedure until the animal's general condition was stable
after operation. Hemorrhagic shock was produced for a period
of 120 minutes by blood-letting via the femoral artery until the
mean arterial blood pressure (MAP) was 6.7 ± 0.67 kPa (50 ±
5 mmHg) in 30 minutes. We then transfused 60% of the lost
blood and lactated Ringer's solution (Otsuica, Tianjing,
China), which was twice as much as the lost blood in 60 min-
utes. The MAP must reach over 80% of the MAP before hem-
orrhagic shock. The experimental pigs were intravenously
injected with 0.5 mg/kg lipopolysaccharide of coli bacillus (E.
colO111B4; Sigma, St Louis, Missouri, USA) 12 hours after the
resuscitation for a period of 24 hours.
Organ function monitoring and supporting
The experimental animals were given electrocardiographic
monitoring and the observed indexes included the MAP, the
breathing rate, the heart rate, the central venous pressure, the
pulmonary arterial pressure, the pulmonary arterial wedge
pressure and the ventricular stroke output. The results of blood
serum examination were monitored. The main observed
indexes included alanine aminotransferase, aspartate ami-
notransferase, creatinine, blood urea nitrogen, white blood cell
count, blood platelet count, arterial oxygen saturation, arterial
partial pressure of oxygen, arterial partial pressure of carbon
dioxide and arterial power of hydrogen measured at seven time
points: 24 hours before the operation (T1), 12 hours after
resuscitation (T2), 24 hours after endotoxemia (T3), 72 hoursAvailable online http://ccforum.com/content/13/4/R118
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after endotoxemia (T4), 96 hours after endotoxemia (T5), 144
hours after endotoxemia (T6), and 168 hours after endotox-
emia (T7).
All of the experimental animals were given circulatory, respira-
tory and metabolic support. Dopamine was intravenously
infused at a dose of 0.5 mg/kg/hour to maintain blood pres-
sure when the heart rate was more than two times that of nor-
mal or the mean arterial pressure was less than 60% of normal.
The animals were mechanically ventilated when the breathing
rate was more than 40 breaths/minute or the arterial partial
pressure of oxygen was below 60 mmHg. A solution of 5%
glucose and 0.9% NaCl (100 to 150 ml/kg/day) (Baxter,
Annapolis, Maryland, USA) with 10% KCl (1 ml/kg/day; Tianyi)
was intravenously infused.
Diagnostic criteria of MODS
The diagnostic criteria of MODS in experimental animals
include the following: pulmonary dysfunction (breathing rate
>40 breaths/minute, arterial partial pressure of oxygen <60
mmHg or arterial partial pressure of carbon dioxide >40
mmHg), cardiac dysfunction (cardiac dysrhythmia, heart rate
more than two times the upper limit of normal, heart rate <60
beats/minute or mean arterial pressure <70% of the upper
limit of normal), coagulation disorders (blood platelet count
<70% of the upper limit of normal or the prothrombin time and
thrombin time were 3 seconds longer than the upper limit of
normal), hepatosis (serum alanine aminotransferase, serum
aspartate aminotransferase or total bilirubin more than two
times that of normal), and renal dysfunction (creatinine or
blood urea nitrogen more than two times the upper limit of nor-
mal. MODS could be diagnosed if two or more criteria can be
met.
Flow cytometry studies
One hundred microliters of peripheral blood and 50 μl bone
marrow in experimental animals at the seven time points
described above were treated with 0.5 mM ethylenediamine-
tetraacetic acid (Sigma-Aldrich Chemie GmbH, Munich, Ger-
many) as anticoagulant and were incubated for 30 minutes in
the dark with activated protein C-labeled monoclonal rabbit
KDR antibody (Lake Placid, New York, USA) and the phyco-
erythrin-labeled polyclonal goat CD133 antibody (Santa Cruz,
California, USA). Isotype-identical antibodies IgG1-PE and
IgG1-APC (Becton Dickinson, Franklin Lakes, New Jersey,
USA) served as controls.
The analysis was carried out using a FACSCalibur flow cytom-
eter with CellQuest software (BD Pharmingen, San Diego,
California, USA). The cell surface expression of KDR was
determined by flow kilometric analysis using 620 to 650 nm
wavelength laser excitations and monitoring the emitted fluo-
rescence with a detector optimized to collect peak emissions
at 660 to 670 nm. The cell surface expression of CD133 was
determined using 488/575 nm excitation and emission wave-
lengths.
Endothelial progenitor cell culture assay
Mononuclear cells were isolated by density-gradient centrifu-
gation with Ficoll (1.077 g/ml; Sigma) from 10 ml peripheral
blood and 2 ml bone marrow in experimental animals at the
seven time points (ethylenediamine tetraacetic acid as antico-
agulant). Immediately after isolation, mononuclear cells were
plated on six-well culture dishes coated with 2% human
fibronectin (Chemicon, Billerica, Massachusetts, USA) at a
density of 1 × 106/cm2 and were maintained in endothelial pro-
genitor cell growth medium-2 (PromoCell, Heidelberg, Ger-
many) for 2 hours. After 2 hours, nonadherent cells were
collected and replated. After 4 days in culture, nonadherent
cells were removed by a thorough washing with PBS. The cul-
ture was maintained through day 7, and adherent cells were
subjected to further examinations.
Characterization of endothelial progenitor cells
Immunohistochemical analysis for confirmation of the pheno-
type and fluorescent chemical detection of EPCs were per-
formed on adherent mononuclear cells after 7 days in culture.
Adherent mononuclear cells were stained with the following
antibodies: monoclonal rabbit KDR antibody (Upstate) and
polyclonal goat CD133 antibody (Santa Cruz). Direct fluores-
cent staining was used to detect dual binding of FITC-labeled
Ulex europaeus agglutinin (UEA-1) (Sigma) and 1,1-dioctade-
cyl-3,3,3,3-tetramethylindocarbocyanine-labeled acetylated
low-density lipoprotein (Dil-ac-LDL; Molecular Probe,
Carlsbad, California, USA). Cells were first incubated with Dil-
ac-LDL at 37°C and were later fixed with 2% paraformalde-
hyde (Tianyi) for 10 minutes. After being washed twice, the
cells were reacted with UEA-1 (10 mg/l) for 1 hour. After the
staining, samples were analyzed using a laser scanning confo-
cal microscope (Leica, Wetzlar, Germany). Cells demonstrat-
ing double-positive fluorescence were identified as
differentiating EPCs.
Migratory and adhesive capacities of the endothelial 
progenitor cell assay
Isolated EPCs were detached using 1 mmol/l ethylenediamine
tetraacetic acid in PBS (pH 7.4), were harvested by centrifu-
gation, were resuspended in endothelial progenitor cell
growth medium-2 and were counted. EPCs (1 × 104) were
added to in the upper chamber of a modified Boyden chamber
with a polycarbonate filter (6.5 mm diameter, 8 μm pore size;
Neuro Probe, Gaithersberg, Maryland, USA), and 500 μl
endothelial progenitor cell growth medium-2 with human
recombinant vascular endothelial growth factor (VEGF) (50
ng/ml) (Peprotech EC, London, UK) was added to the bottom
chamber. After 24 hours of incubation at 37°C and 5% carbon
dioxide, the lower side of the filter was washed with PBS and
fixed with 2% paraformaldeyde. For quantification of migrated
cells, cell nuclei were stained with Giemsa (Dade Behring,Critical Care    Vol 13 No 4    Luo et al.
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Marburg, Germany). Migrated cells in the lower chamber were
counted manually in five random microscopic fields.
Fibronectin (100 μg/ml) was coated onto 96-well plates and
left for 12 hours at 37°C. The first passages of EPCs at differ-
ent time points were added into endothelial progenitor cell
growth medium-2 at a density of 1 × 104/ml. Then the medium
was added into these plates with 1 ml/well and left to attach
for 30 minutes. For quantification of migrated cells, cell nuclei
were stained with Giemsa (Dade Behring). Attached cells
were counted manually in five random microscopic fields.
Angiogenesis assay
An angiogenesis assay plate (BD Pharmingen) was used to
assay the angiogenetic capabilities of EPCs. The 96-well
black plate (BD Pharmingen) with a clear bottom uniformly
coated with BD Matrigel Matrix was allowed to polymerize for
30 minutes at 37°C and 5% carbon dioxide. The first passage
of EPCs was added at different time points to the wells at a
density of 1 × 105/well. The angiogenesis assay plate was
incubated for 24 hours at 37°C, 5% carbon dioxide. For each
plate, 6.25 ml Hank's balanced saline solution (HBSS) (BD
Pharmingen) was measured out and warmed to 37°C. We
added 20 μl dimethylsulfoxide (BD Pharmingen) to each 50 μg
vial of Calcein AM (8 μg/ml) solution (BD Pharmingen), and
then added approximately 100 μl warm (37°C) HBSS to the
vial. Following incubation, the medium was carefully removed
from the plates. The plates were washed by adding 100 μl
HBSS to each well, and the EPCs were then labeled by add-
ing 50 μl/well of 8 μg/ml Calcein AM in HBSS and the plates
were incubated for 30 minutes at 37°C, 5% carbon dioxide.
The labeling solution was removed and the plates washed
twice, and we then counted the tubes in the plate using a flu-
orescent microscope.
Statistical analysis
Data are expressed as the mean ± standard deviation.
Descriptive statistics were made on all test variables. A two-
sample t test was used to compare the mean values of varia-
bles among the two groups of experimental animals, whereas
the chi-square test was used to compare proportions on the
normally distributed variables. A two-sample Wilcoxon rank
sum test was used for variables that were not normally distrib-
uted. P < 0.05 was considered significant.
Results
Important organ function of animals and incidence of 
MODS
All of the animals in the experimental group presented MODS
(100%) and 17 out of 20 animals (85%) died in the phase of
observation. A total of 15 animals (75%) developed MODS in
the midanaphase of the sepsis (69 to 144 hours post hemor-
rhagic shock + resuscitation + endotoxemia). In all of the ani-
mals with MODS, dysfunction of two organs occurred in seven
cases, dysfunction of three organs occurred in eight cases
and dysfunction of more than four organs occurred in five
cases. The incidence of MODS and death of the animals in the
control group were 0% (P < 0.01).
In the experimental group, the incidence of pulmonary dysfunc-
tion was the 80% (16 cases), the incidence of cardiac dys-
function was 65% (13 cases), the incidence of hepatosis was
55% (11 cases), the incidence of renal dysfunction was 35%
(seven cases) and the incidence of coagulation disorders was
35% (seven cases). Pulmonary dysfunction and cardiac dys-
function occurred earlier than any other organ dysfunction in
the course of sepsis. The breath rate began to increase and
the oxygen pressure (PO2) began to decrease sharply at 72
hours after endotoxemia (T4) and continually increased to
peak at 144 hours after endotoxemia (T6). The values of the
heart rate, the MAP, alanine aminotransferase, total bilirubin,
the prothrombin time, serum creatinine and serum blood urea
nitrogen had similar changes. The values of the blood platelet
count began to decrease at T4 and decreased sharply to the
bottom at T5. All of the values of the survival animals normal-
ized gradually during 120 to 144 hours after endotoxemia.
Number of endothelial progenitor cells in the 
progression of MODS
The number of EPCs in peripheral circulation and bone mar-
row decreased sharply in the progression of MODS. In the
experimental group, the number of EPCs in peripheral circula-
tion increased after hemorrhagic shock and continually
increased to peak in the earlier phase of sepsis (72 hours after
endotoxemia). With the progression of MODS the number of
EPCs would decrease sharply until death, but the number of
EPCs in surviving animals would begin to increase at the
144th hour after endotoxemia. Similar changes of EPCs in
peripheral circulation were also found in bone-marrow-derived
EPCs, but the magnitude of changes was greater and the tim-
ing point of the increase was earlier (24 hours after endotox-
emia). In the control group, the number of EPCs in peripheral
circulation and in the bone marrow increased a little after oper-
ation but quickly returned to normal (Figure 1).
Endothelial progenitor cell culture assay
The mononuclear cells were round or oval and none was
attached at the first day of culture. Alignments of spindle cells
were observed after 3 days of culture. After 7 days of culture,
some of the EPCs formed a cobblestone-like structure and
took part in network formation. Some rod-shaped organelles
(Weible-Palade bodies) that were deemed the characteristic
structure of EPCs could be observed in cell plasma by trans-
mission electron microscopy (Figure 2).
Characterization of endothelial progenitor cells
The attached spindle cells at different points were all positive
for taking up Dil-ac-LDL and UEA-1. Co-staining cells revealed
that more than 90% of adherent cells are both Dil-ac-LDL-pos-
itive and UEA-1-positive. Additional staining revealed thatAvailable online http://ccforum.com/content/13/4/R118
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more than 90% of the cultured cells were positive for KDR and
CD133 (Figure 3).
Migratory and adhesive capacities of endothelial 
progenitor cells in the progression of MODS
In the experimental group, the migratory and adhesive capaci-
ties of EPCs in both peripheral circulation and the bone mar-
row increased quickly after hemorrhagic shock and continually
increased to peak in the earlier phase of sepsis (24 hours after
endotoxemia). With the progression of MODS the migratory
and adhesive capacities of EPCs would decrease quickly and
sharply until death, but they would begin to increase at the
120th hour after endotoxemia in the surviving animals. Similar
changes of migratory and adhesive capacities of EPCs in
peripheral circulation were also found in the EPCs from bone
marrow. Moreover, the time point for the decrease of migratory
and adhesive function was earlier than that of the number of
EPCs. In the control group, the migratory and adhesive func-
tion of EPCs in both peripheral circulation and the bone mar-
Figure 1
Number of endothelial progenitor cells during progression of multiple organ dysfunction syndromes Number of endothelial progenitor cells during progression of multiple organ dysfunction syndromes. The number of endothelial progenitor cells in 
(left) peripheral blood and (right) bone marrow. *P < 0.05, **P < 0.01.
Figure 2
Endothelial progenitor cell morphology during ex vivo culture Endothelial progenitor cell morphology during ex vivo culture. (a) Mononuclear cells are able to differentiate into spindle cells 48 hours after cul-
ture.(b) Colony of endothelial progenitor cells (EPCs) observed after 7 or 8 days of culture. (c) and (d) After 7 days of culture, the ultrastructure of 
EPCs can be observed by electron microscope. Black arrow, Weible-Palade body that was the characteristic structure of EPCs. Magnification: (a) 
and (b) ×100; (c) ×5,000; (d) ×30,000.Critical Care    Vol 13 No 4    Luo et al.
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row increased a little after operation but quickly returned to
normal (Figure 4).
Angiogenesis assay
The number of tubes in the plate was used to illustrate the ang-
iogenesis function of EPCs at different time points. The results
showed that the angiogenesis function of EPCs from periph-
eral circulation was stronger than that from bone marrow. In
the experimental group, the angiogenesis function of EPCs in
both peripheral circulation and the bone marrow would
increase gradually after hemorrhagic shock and continually
increased to peak in the metaphase of sepsis (72 hours after
endotoxemia). The angiogenesis function of EPCs in both
peripheral circulation and the bone marrow would decrease
gradually with the progression of MODS, but was still stronger
than normal. In the control group, the angiogenesis function of
EPCs in peripheral circulation and the bone marrow main-
tained normal status without much change (Figures 5 and 6).
Discussion
The present study observed for the first time that the number
and function of EPCs decreased sharply in the progression of
MODS, and the decrease was prior to the occurrence of
MODS in the experimental animals. There have been several
studies focused on the relation between EPCs and sepsis [8-
10], but no systematic studies existed regarding pathological
variations in the number and function of EPCs in vivo in MODS
and there was no agreement in the change of EPCs in MODS
caused by severe sepsis.
Mayr and colleagues detected that EPCs would decrease to a
nadir 6 hours after infusion of sepsis and would return to val-
ues comparable with baseline 24 hours after lipopolysaccha-
ride of coli bacillus challenge [10], and conceived that the
200-fold increase in TNF outweighed the comparably moder-
ate increases in VEGF and granulocyte colony-stimulating fac-
tor (G-CSF) that finally resulted in a net EPC decrease. We
suggested, however, that such a low-grade endotoxemia
model may not be deemed a sepsis model, which may partly
explain the different results between our experiment. Rafat and
colleagues [9] found that the circulation endothelial progenitor
cells (CEPCs) increased from the 6th hour after diagnosis as
sepsis and remained high during the sepsis phase, but none
had significantly low numbers of EPCs [9]. In our experiment,
all of the animals in the experimental group presented MODS
and most of them died. The results in the nonsurviving animals
were similar to the study of Rafat and colleagues [9] but the
EPCs of surviving animals decreased sharply in the progres-
sion of MODS and began to increase in the 144th hour after
endotoxemia, which may be caused by more severe sepsis.
This may have caused the difference between our two studies.
Our study lends further support to the previous observations
that the EPC number and function decreases with advancing
sepsis. We also deemed that the pool of EPCs would be
Figure 3
Characterization of endothelial progenitor cells Characterization of endothelial progenitor cells. At 7 days of culture, immunohistochemical staining revealed that more than 90% of the cultured 
cells are positive to (a) CD133 and (b) vascular endothelial growth factor receptor-2. Endothelial progenitor cells were incubated with 1,1-dioctade-
cyl-3,3,3,3-tetramethylindocarbocyanine-labeled acetylated low-density lipoprotein (Dil-Ac-LDL) and stained with Ulex europaeus agglutinin (UEA-1). 
Fluorescence microscopy illustrates that endothelial progenitor cells are positive for (c) Dil-Ac-LDL and (d) Dil-Ac-LDL and UEA-1. Magnification: 
×100.Available online http://ccforum.com/content/13/4/R118
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exhausted and the repair capacity would be impaired by
severe trauma and inflammation, which would accelerate the
progression of MODS. We therefore postulate that autolo-
gous transplantation of EPCs may play an important role in the
prevention and treatment of MODS.
The pathogenesis of MODS was so complicated that we did
not investigate the correlation between the number and
capacity of EPCs and the other factors of MODS in the
present study. The mechanisms for the decrease in the
number and function of EPCs in the progression of MODS still
remain to be determined. Another limitation of the present
study was that the functional activity of EPCs was tested in
vitro, and the results of this analysis may not necessarily corre-
late well with the response in vivo. Whether EPCs could dif-
ferentiate to mature ECs in vivo to prevent the progression of
MODS requires further investigation.
In the present study, the level of EPCs in peripheral circulation
and in the bone marrow was directly quantified by flow cytom-
etry measurement of the percentage of CD133/KDR double-
positive mononuclear cells. There is still controversy about
which markers should be used to characterize the EPCs.
According to recent studies [11,12], EPCs were defined as
cells positive for both hematopoietic stem cell markers and
endothelial markers, such as CD133, CD34 and KDR. CD133
and CD34 were deemed the two main hematopoietic stem cell
markers. Unlike CD34, however, CD133 was not expressed
on mature ECs [9]. CD133/KDR double-positive cells could
therefore more probably reflect EPCs.
The results demonstrate that the number of EPCs and the
migratory and adhesive capacities of EPCs increased quickly
after hemorrhagic shock and continually increased to peak in
the earlier phase of sepsis. With the progression of MODS,
these factors would decrease sharply until death; and the
decrease of migratory and adhesive capacities of EPCs was
prior to the decrease of the number of EPCs. The angiogen-
esis function of EPCs from peripheral circulation was stronger
than that from bone marrow and would change gradually after
Figure 4
Migratory and adhesive capacities of endothelial progenitor cells during progression of multiple organ dysfunction syndromes Migratory and adhesive capacities of endothelial progenitor cells during progression of multiple organ dysfunction syndromes. The (top) migratory 
capacities and (bottom) adhesive capacities of endothelial progenitor cells in (left) peripheral blood and (right) bone marrow. *P < 0.05, **P < 0.01.Critical Care    Vol 13 No 4    Luo et al.
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injuries. The angiogenesis function would, however, still be
stronger than normal even until death. The results showed that
the occurrence of the decrease of the number and function of
EPCs was prior to the occurrence of MODS, so the sharp
decrease in the number and function of EPCs in the progres-
sion of MODS may be one of the main pathogenic factors of
MODS. In the present study, the migratory, adhesive and ang-
iogenesis capacities of EPCs were detected on the EPCs that
had been cultured for 7 days in vitro because we could not
isolate EPCs directly. We found that these functions of EPCs
would remain stable after short-time culturation. The functions
of EPCs were therefore deemed able to reflect the functions
of EPCs in vivo.
The unique angiogenic capacity of EPCs renders them optimal
candidates for cell-based therapies. Recent studies have
described that both peripheral circulation and the bone mar-
row can be used as a source of EPCs, which have the poten-
tial to differentiate into functional ECs under specific culture
conditions [12]. The methods in previous studies of purifying
and culturing EPCs had always relied on magnetic bead or
cytofluorometric selection for cells expressing CD34, KDR, or
CD133 [13,14]. In our research we showed that EPCs could
be isolated from peripheral circulation and the bone marrow
based on their adherence and requirement for specific growth
conditions as ECs without any further enrichment steps. We
also identified cultured EPCs by taking up Dilac-LDL as well
as UEA-1 and by other phenotype confirmation. Our results
showed that more than 90% of the adherent cells could take
up both Dil-ac-LDL and UEA-1, and KDR and CD133 positive.
The method of isolation and culture of EPCs is therefore feasi-
ble and may provide adequate cells for cell-based vasculogen-
esis therapy.
Another important finding was that the angiogenic capacity of
EPCs in peripheral circulation was stronger than that of the
Figure 5
Angiogenic capacity of endothelial progenitor cells during progression of multiple organ dysfunction syndromes Angiogenic capacity of endothelial progenitor cells during progression of multiple organ dysfunction syndromes. The angiogenic capacity of 
endothelial progenitor cells in (left) peripheral blood and (right) bone marrow. *P < 0.05, **P < 0.01.
Figure 6
Angiogenesis function of endothelial progenitor cells Angiogenesis function of endothelial progenitor cells. Angiogenesis function of endothelial progenitor cells with Calcein added, observed by (a) 
phase-contrast microscope and (b) fluorescent microscope. Magnification: ×400.Available online http://ccforum.com/content/13/4/R118
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EPCs from bone marrow and remained stable in the progres-
sion of MODS. The capacity indicated that EPCs in peripheral
circulation had changed after being mobilized from the bone
marrow. In recent studies two different EPC subpopulations
have been described, denoted as early EPCs and late EPCs,
with distinct cell growth patterns and ability to secrete ang-
iogenic factors [15,16]. Early EPCs are spindle-shaped cells,
including the EPCs in the bone marrow and the EPCs just
mobilized to peripheral circulation [17]. Late EPCs are cobble-
stone shaped, including the EPCs mobilized to peripheral cir-
culation and precursors of mature ECs [17,18]. Our results
show that late EPCs had stronger angiogenic capacity than
that of early EPCs; therefore, late EPCs could play a more
important role in angiogenesis in cell-based therapy for
ischemic diseases.
Conclusions
The present study demonstrates, for the first time, the change
in number and in function of EPCs in peripheral circulation and
in the bone marrow in MODS, and found that the number and
function of EPCs would decrease in the progression of MODS
and may be one of the main pathogenic factors of MODS. The
results of this study may therefore be extended to more clinical
implications, but further prospective studies are needed to
evaluate whether the level of EPCs can serve as a valuable
biological marker and can be used for the stratification of
patients with MODS.
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